Navigation Links
Beta-Pro Donates Human Islet Cells to Diabetes Researcher
Date:9/22/2010

GORDONSVILLE, Va., Sept. 22 /PRNewswire/ -- The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co. Professor of Pediatric Diabetes, Indiana University School of Medicine, Herman B. Wells Center for Pediatric Research. Dr. Mirmira and colleagues subsequently published their work in leading scientific journals, including, The Journal of Clinical Investigation* and The Journal of Biological Chemistry.**

"Beta-Pro has been our exclusive source of human islets for the last two years," said Dr. Mirmira.  "We have been delighted with both the frequency and quality of islets, which are now a crucial component of our NIH and JDRF-funded research projects."

"We want to congratulate Dr. Mirmira on the publication of his manuscripts in these peer-reviewed journals and on his ongoing research efforts in beta-cell generation," said Beta-Pro Principle Scientific Advisor and Professor of Surgery at the University of Virginia, Kenneth L. Brayman, M.D., Ph.D. "We appreciate Dr. Mirmira citing Beta-Pro LLC as a source for human islets and wish him the best of luck in his future study of diabetes at the IU School of Medicine."

Dr. Mirmira serves as a member of the Diabetes, Endocrinology and Metabolic Diseases B Subcommittee of the Diabetes and Digestive and Kidney Diseases Initial Review Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, and on the editorial boards for the journals Diabetes, Molecular Endocrinology, and American Journal of Physiology-Endocrinology and Metabolism.

Beta-Pro isolates and distributes insulin-producing islet cells from surplus organs not placed for whole organ transplant in GMP and GLP facilities. Beta-Pro then charges and recovers fees for the costs for organ procurement, processing, preservation, quality control, storage, handling, and delivery of islets, other biomaterials, and biological data.  To learn more, visit the new Web site at www.betaprolabs.com.

*Maier, B., Ogihara, T., Trace, A.P., Tersey, S.A., Robbins, R.D., Chakrabarti, S.K., Nunemaker, C.S., Stull, N.D., Taylor, C.A., Thompson, J.E., Dondero, R.S., Lewis, E.C., Dinarello, C.A., Nadler, J.L., and Mirmira, R.G. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest. 2010; 120(6):2156-21702.

**Ogihara, T., Chuang, J.C., Ogihara, T., Chuang, J.C., Vestermark, G.L., Garmey, J.C., Ketchum, R.J., Huang, X., Brayman, K.L., Thorner, M.O., Repa, J.J., Mirmira, R.G., and Evans-Molina, C. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem. 2010; 285(8):5392-5404.Contact:

John Kelly PR(434) 296-5577john@johnkellypr.com
'/>"/>

SOURCE Beta-Pro LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability
2. SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools
3. GeneGo Donates Proprietary Cytokine Pathway Maps to ISICR
4. Vita-Tech International, Inc. Donates One Ton of Vitamins To Polio Treatment Centers in Guinea, West Africa
5. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
6. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
7. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
8. UC Riverside researcher develops novel method to grow human embryonic stem cells
9. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
11. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... Equicare Health Inc ., the leading supplier of comprehensive ... the top 100 companies in the 2016 Global Digital ... top digital health companies across the globe.   ... continually upgrading our product with the ongoing digital shift ... Len Grenier , CEO of Equicare Health, "It,s ...
(Date:11/30/2016)... 2016   Merck , ein führendes ... einer Reihe von Vereinbarungen mit Evotec AG ... Screeningleistungen für Mercks Palette genetischer Reagenzien wie ... diese Bibliotheken in Kombination mit Evotecs Expertise ... zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... ... , ... SSCI, the established leader in small-molecule cocrystal technology and development, will ... on pharmaceutical cocrystals as drug substance . The Lunch and Learn will ... follows the successful November 15th event that took place in Burlingame, CA. Eyal H. ...
(Date:11/30/2016)... ... November 30, 2016 , ... On 28 November 2016, the International Union ... nihonium (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, ... earlier proposed by the discoverers have been approved by the IUPAC Bureau. The IUPAC ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
Breaking Biology News(10 mins):